TP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy. [electronic resource]
Producer: 20180828Description: 1010428318794217 p. digitalISSN:- 1423-0380
- A549 Cells
- Animals
- Cell Line, Tumor
- Colonic Neoplasms -- diet therapy
- Doxorubicin -- pharmacology
- Female
- Genes, p53 -- drug effects
- HCT116 Cells
- Hep G2 Cells
- Humans
- MCF-7 Cells
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Osteosarcoma -- drug therapy
- Protein Kinase Inhibitors -- pharmacology
- Signal Transduction -- drug effects
- Tumor Suppressor Protein p53 -- genetics
- src-Family Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.